Hub : Traits :

Comparative body size at age 10

1260 significantly associated models · 321 unique genes.

Significant Loci

# chr p0 p1 # assoc genes # joint genes best TWAS P best SNP P cond SNP P % var exp joint genes
1 1 959842 2404256 2 1 4.1e-08 2.2e-07 1.4e-01 92 NADK
2 1 5611729 7016109 1 1 1.6e-07 1.3e-11 2.2e-07 42 GPR153
3 1 15154630 16613660 1 1 1.8e-08 2.3e-06 9.2e-01 100 DNAJC16
4 1 28823671 30246262 1 1 1.7e-07 3.1e-06 1.8e-01 92 MECR
5 1 53996718 55567410 1 1 1.2e-07 1.9e-09 1.9e-03 73 SSBP3
6 1 61448835 63322743 2 2 2.9e-08 1.4e-10 7.8e-01 100 INADL TM2D1
7 1 65189751 66803080 2 1 5.3e-13 1.4e-12 7.0e-04 77 LEPR
8 1 71163715 73435171 1 1 9.6e-27 8.9e-29 7.4e-06 84 NEGR1
9 1 73966076 75922251 2 2 9.3e-19 7.9e-61 1.8e-36 41 FPGT TYW3
10 1 109316076 110733794 2 1 3.5e-10 1.4e-08 3.1e-03 73 ATXN7L2
11 1 112312154 113857970 2 1 1.2e-07 1.3e-06 6.7e-02 86 ST7L
12 1 155172725 156572984 1 1 1.1e-07 2.1e-07 3.4e-01 97 RIT1
13 1 177195050 178753162 5 4 2.5e-27 3.7e-116 7.7e-60 49 RASAL2-AS1 RP11-568K15.1 SEC16B
14 1 204982713 206329620 5 1 4.2e-10 2.1e-09 1.0e+00 100 PM20D1
15 2 15703 1384725 4 3 8.9e-16 5.0e-83 1.2e-64 23 SH3YL1 TMEM18
16 2 23604114 26088769 11 12 1.4e-114 2.1e-100 NaN NaN ADCY3 DNAJC27 FAM228B NCOA1 POMC PTRHD1 TP53I3
17 2 66927859 68326904 1 1 2.9e-08 3.5e-09 3.0e-03 75 ETAA1
18 2 95984930 97623413 2 1 2.2e-07 2.0e-07 1.0e+00 100 TMEM127
19 2 160095086 161610478 1 1 1.9e-08 8.8e-07 6.0e-03 69 PLA2R1
20 2 187360440 189113345 2 1 6.8e-08 3.4e-08 1.0e+00 100 CALCRL
21 2 206159496 209182548 4 2 4.3e-08 9.6e-13 8.4e-09 35 ADAM23 METTL21A
22 2 241477073 242953866 1 1 1.2e-07 5.5e-06 5.7e-01 98 HDLBP
23 3 10617048 12457119 2 1 1.2e-14 2.6e-14 8.2e-04 81 ATG7
24 3 46730749 49181885 8 1 1.2e-09 4.2e-09 5.2e-02 89 PTPN23
25 3 49615624 51320800 9 1 1.8e-11 4.0e-08 1.6e-03 67 RASSF1
26 3 84317575 86808226 1 1 4.8e-12 5.3e-18 1.8e-07 64 CADM2
27 3 87495550 88911119 2 1 3.5e-09 7.2e-09 1.0e+00 100 C3orf38
28 3 140514022 142017527 1 1 2.0e-09 5.4e-11 7.2e-04 73 RASA2
29 4 55598706 57110821 1 1 1.2e-07 6.7e-06 1.6e-01 90 CLOCK
30 5 63328721 64762465 1 2 1.5e-08 6.0e-14 1.1e-05 66 SREK1IP1
31 5 74115338 75704085 2 1 2.3e-08 1.0e-08 2.3e-03 72 POLK
32 5 87006055 88429077 1 1 3.5e-07 9.4e-12 4.3e-07 45 CTC-498M16.2
33 5 175819032 177138298 1 1 6.9e-08 9.9e-07 3.4e-01 96 FGFR4
34 6 34065982 36158878 2 2 1.3e-08 7.3e-08 1.6e-02 80 TEAD3 UHRF1BP1
35 6 41042590 42443108 1 1 2.3e-10 1.5e-11 1.0e+00 100 FRS3
36 6 42496457 43892938 1 1 2.9e-07 8.4e-07 8.7e-06 18 DNPH1
37 6 49982048 51431253 1 1 2.1e-08 6.3e-34 8.2e-30 13 TFAP2D
38 6 52815766 54227991 1 1 2.1e-07 9.0e-12 4.2e-11 6 KLHL31
39 6 104706579 106230491 1 1 2.9e-09 1.1e-08 5.1e-02 88 LIN28B
40 7 32470370 34339347 1 1 1.3e-08 3.2e-07 1.0e+00 100 BBS9
41 7 75913086 77370662 1 1 2.5e-08 8.3e-08 1.7e-01 94 DTX2P1-UPK3BP1-PMS2P11
42 7 92169872 93683737 1 1 4.4e-09 2.7e-16 4.9e-10 42 CCDC132
43 7 101402732 102807435 2 1 3.3e-08 1.3e-06 1.2e-01 89 LRWD1
44 7 138121329 139565916 1 1 3.1e-08 8.4e-09 1.0e+00 100 TTC26
45 8 8092025 12973575 35 12 5.6e-14 1.9e-13 NaN NaN AF131215.2 AF131215.9 AF131216.5 CLDN23 FAM85A MFHAS1 PINX1 TDH
46 9 95186937 96913764 3 2 2.8e-13 3.2e-17 1.4e-05 74 FAM120AOS RP11-165J3.6
47 9 97828471 99324377 2 1 9.7e-09 5.0e-12 8.7e-05 68 LINC00476
48 10 120954350 122399277 1 1 1.4e-07 1.3e-07 5.6e-02 87 SEC23IP
49 11 26818083 29054545 3 2 2.4e-12 2.7e-17 2.0e-05 75 LIN7C METT5D1
50 11 46543524 48783497 16 10 1.0e-22 3.0e-18 1.0e+00 100 ACP2 C1QTNF4 MADD MTCH2 NDUFS3 Y_RNA
51 11 64669105 67294308 8 2 1.6e-11 5.4e-11 6.7e-02 92 C11orf80 MAP3K11
52 11 67339278 70179848 3 3 2.7e-10 4.5e-13 1.2e-04 72 C11orf24 IGHMBP2 ORAOV1
53 12 48605088 51365312 23 11 9.5e-58 4.1e-82 NaN NaN BCDIN3D C12orf62 C1QL4 CERS5 FAIM2 LIMA1 LMBR1L RP11-386G11.10 SMARCD1
54 12 119870094 121330086 1 1 3.2e-07 6.1e-07 5.5e-02 85 GCN1L1
55 13 27300215 29410882 5 4 7.9e-10 7.2e-17 9.0e-08 59 AL137059.1 FLT3 MTIF3 PAN3-AS1
56 15 23641196 24625502 1 1 1.3e-09 7.1e-09 5.7e-02 89 NDN
57 15 66998610 68825675 3 4 1.5e-22 6.1e-29 6.2e-06 84 MAP2K5
58 15 83167559 84573491 1 1 3.7e-07 1.8e-07 1.4e-01 92 HDGFRP3
59 16 2890210 4855279 4 2 1.6e-20 1.2e-24 1.9e-07 74 ADCY9 NLRC3
60 16 18886254 21147999 8 2 1.7e-37 2.1e-37 1.0e+00 100 ACSM5 GPRC5B
61 16 27655848 31833122 56 2 4.6e-18 8.9e-17 1.0e+00 100 RP11-347C12.2 SH2B1
62 16 52772129 54846383 3 3 2.9e-41 8.5e-183 9.6e-91 51 AKTIP FTO RBL2
63 16 66262051 68674788 8 1 7.6e-13 8.5e-13 1.0e+00 100 ATP6V0D1
64 16 80779331 82439714 1 1 2.6e-08 5.5e-11 1.7e-04 67 CMIP
65 17 1263564 2953418 5 1 5.9e-14 1.5e-13 3.7e-01 99 SRR
66 17 26706946 28172357 1 1 7.2e-08 4.5e-06 2.1e-02 75 MYO18A
67 17 34157655 35675511 4 1 3.3e-10 1.9e-10 1.0e+00 100 GGNBP2
68 17 43871147 43913030 1 1 6.7e-09 6.4e-03 8.0e-02 59 KANSL1
69 18 20393480 21863589 2 1 1.8e-08 2.7e-07 7.8e-01 100 C18orf8
70 18 38837001 40365619 1 1 1.5e-07 3.0e-07 3.6e-02 83 PIK3C3
71 18 57349900 58729694 1 1 4.9e-18 2.1e-69 5.1e-54 23 MC4R
72 18 76456503 77984604 1 1 1.4e-07 3.6e-08 1.0e-02 78 NFATC1
73 19 1473344 2923263 1 1 1.3e-07 7.9e-07 9.5e-02 89 DOT1L
74 19 18451661 20313262 6 4 1.7e-10 7.7e-10 3.4e-07 31 ARMC6 HAPLN4 MEF2B TMEM161A
75 19 37464375 38861362 1 1 2.7e-07 1.7e-05 8.7e-01 100 ZNF781
76 19 46923752 48406374 1 1 3.3e-07 5.0e-17 2.5e-12 30 SAE1
77 19 48505468 49906278 1 1 1.7e-07 2.1e-07 1.4e-01 92 FUT2
78 22 21798199 23002699 2 1 1.5e-09 2.7e-09 3.2e-01 97 PPM1F
79 22 40061683 42784201 4 3 3.0e-08 4.4e-13 3.2e-03 84 ADSL NHP2L1 SLC25A17

Pleiotropic Associations

Trait chisq ratio # genes+ # genes++ % genes++ corr corr P genes
Alzheimer’s Disease (including proxy) 1.29 1 0 0.0 0.00 1.0e+00 MADD
Crohns Disease (2017) 1.72 5 3 9.1 0.87 1.1e-02 ADCY3 DNAJC27 FUT2 PTRHD1 SH2B1
Irritable Bowel Disease (IBD) 1.59 7 2 6.1 0.84 4.8e-03 ADCY3 DNAJC27 NADK NCOA1 PTRHD1 SH2B1 ST7L
Ulcerative Colitis (UC) 1.12 1 0 0.0 0.00 1.0e+00 SH2B1
Major Depression (MDD) 1.39 1 1 3.0 0.00 1.0e+00 NEGR1
Reaction Time 1.62 4 1 3.0 0.60 4.0e-01 ADCY3 KANSL1 PM20D1 TP53I3
Verbal and Numeric Reasoning (VNR) 2.01 9 6 18.2 0.05 9.0e-01 ADCY3 C1QTNF4 GGNBP2 MADD MTCH2 NDUFS3 NEGR1 SH2B1 Y_RNA
Breast Cancer 2.27 10 5 15.2 -0.81 2.3e-03 ADCY3 AKTIP C11orf80 DNAJC27 DNPH1 FTO HAPLN4 RIT1 SLC25A17 TMEM161A
Prostate Cancer 1.71 1 0 0.0 0.00 1.0e+00 PM20D1
Age at First Birth 1.24 1 0 0.0 0.00 1.0e+00 PTPN23
Bipolar Disorder 1.61 1 0 0.0 0.00 1.0e+00 LMBR1L
Body Mass Index (BMI) (2010) 7.20 21 14 42.4 -0.90 1.0e-10 ADCY3 AKTIP AL137059.1 C1QTNF4 CERS5 DNAJC27 DTX2P1-UPK3BP1-PMS2P11 FAIM2 FTO GPRC5B LIN7C MADD MAP2K5 MC4R MTCH2 NDUFS3 NEGR1 POLK RASA2 SAE1 Y_RNA
Crohns Disease (2012) 1.48 3 0 0.0 -0.34 6.6e-01 ADCY3 FUT2 RIT1
Fasting Glucose 1.28 1 1 3.0 0.00 1.0e+00 MADD
HDL Cholesterol 2.70 8 7 21.2 0.83 5.7e-03 ACP2 ATP6V0D1 C1QTNF4 MADD MTCH2 NDUFS3 UHRF1BP1 Y_RNA
LDL Cholesterol 1.68 3 2 6.1 0.00 1.0e+00 ATXN7L2 MEF2B POLK
Lupus 1.75 4 1 3.0 -0.01 9.8e-01 AF131215.2 AF131215.9 AF131216.5 FAM85A
Neuroticism 3.61 10 7 21.2 0.97 6.2e-09 AF131215.2 AF131215.9 AF131216.5 C1QTNF4 CLDN23 FAM85A MADD MFHAS1 MTCH2 TDH
Primary Biliary Cirrhosis 1.20 1 0 0.0 0.00 1.0e+00 ZNF781
Schizophrenia 1.39 3 1 3.0 0.00 1.0e+00 DNPH1 SLC25A17 TMEM161A
Triglycerides 1.75 3 1 3.0 0.00 1.0e+00 MEF2B SAE1 TMEM161A
Blood Eosinophil Count 1.34 17 11 33.3 -0.07 8.0e-01 ADCY3 ARMC6 ATP6V0D1 DNAJC27 HAPLN4 LIN7C MAP2K5 MAP3K11 METT5D1 NHP2L1 RASSF1 RP11-347C12.2 SMARCD1 TEAD3 TMEM127 TMEM161A TTC26
Blood Platelet Count 1.67 26 24 72.7 0.38 4.0e-02 ACP2 ARMC6 C1QTNF4 C3orf38 CERS5 ETAA1 FUT2 GPRC5B HAPLN4 KANSL1 LIMA1 MADD MAP3K11 MTCH2 MYO18A NDUFS3 NHP2L1 ORAOV1 POLK RASSF1 SMARCD1 ST7L TEAD3 TMEM161A UHRF1BP1 Y_RNA
Blood Red Count 0.98 22 9 27.3 0.36 1.0e-01 ACSM5 ADSL C12orf62 C3orf38 CERS5 CLOCK CTC-498M16.2 DNAJC16 DNPH1 DOT1L KANSL1 MAP2K5 MYO18A NCOA1 NFATC1 PTPN23 RASA2 RASSF1 RP11-347C12.2 SAE1 SH2B1 TFAP2D
Blood White Count 1.90 25 17 51.5 -0.40 2.7e-02 ACP2 ADCY3 C12orf62 C1QTNF4 CALCRL CERS5 CTC-498M16.2 FAM228B LIMA1 MADD MAP2K5 MTCH2 NCOA1 NDUFS3 ORAOV1 PLA2R1 PTPN23 PTRHD1 RP11-347C12.2 SAE1 SMARCD1 SRR TEAD3 TP53I3 Y_RNA
Heel T-Score 1.75 32 23 69.7 -0.39 2.6e-02 ACP2 ACSM5 ADCY9 ADSL ATG7 C11orf24 C12orf62 C1QTNF4 CALCRL CERS5 DOT1L FAIM2 GCN1L1 GPR153 GPRC5B HDLBP IGHMBP2 LIMA1 LIN28B MADD MAP2K5 MAP3K11 MTCH2 MYO18A NCOA1 NEGR1 NFATC1 NHP2L1 RP11-347C12.2 SLC25A17 ST7L TMEM127
BMI 8.78 75 63 190.9 -0.95 1.0e-47 ACP2 ACSM5 ADCY3 ADCY9 AKTIP AL137059.1 ATG7 ATXN7L2 C11orf24 C12orf62 C18orf8 C1QTNF4 C3orf38 CADM2 CERS5 CMIP CTC-498M16.2 DNAJC16 DNAJC27 DTX2P1-UPK3BP1-PMS2P11 FAIM2 FAM228B FLT3 FPGT FRS3 FTO GGNBP2 GPR153 GPRC5B HAPLN4 IGHMBP2 INADL LIN7C MADD MAP2K5 MC4R METTL21A MTCH2 MTIF3 NADK NCOA1 NDUFS3 NEGR1 NLRC3 ORAOV1 PIK3C3 PM20D1 POLK POMC PTPN23 PTRHD1 RASA2 RASAL2-AS1 RASSF1 RBL2 RIT1 RP11-347C12.2 RP11-568K15.1 SAE1 SEC16B SH2B1 SH3YL1 SLC25A17 SREK1IP1 SRR SSBP3 TEAD3 TFAP2D TM2D1 TMEM18 TP53I3 TTC26 TYW3 UHRF1BP1 Y_RNA
Height 2.56 50 37 112.1 0.67 6.4e-09 ACP2 ADCY3 ADCY9 AL137059.1 ATP6V0D1 C11orf24 C18orf8 C1QTNF4 C3orf38 CLDN23 CLOCK CMIP DNAJC27 DOT1L FAM228B FGFR4 FRS3 FUT2 GPRC5B HAPLN4 HDLBP KANSL1 LIN28B LIN7C LINC00476 LRWD1 MADD MAP3K11 MC4R METT5D1 MTCH2 NCOA1 NDUFS3 NHP2L1 PM20D1 POMC PTPN23 PTRHD1 RASSF1 RP11-165J3.6 RP11-386G11.10 SEC23IP SH3YL1 SMARCD1 ST7L TM2D1 TP53I3 UHRF1BP1 Y_RNA ZNF781
Waist Hip Ratio (WHR) 1.51 17 11 33.3 0.20 4.2e-01 ACSM5 ADAM23 CALCRL CLOCK DNPH1 DOT1L ETAA1 FGFR4 FTO KANSL1 MAP3K11 MECR NCOA1 NLRC3 ORAOV1 RASSF1 UHRF1BP1
Systolic Blood Pressure 2.37 23 19 57.6 0.74 7.5e-06 ACP2 ADCY3 ATG7 C1QTNF4 C3orf38 CADM2 DNAJC27 FUT2 GPR153 LIN7C MADD MECR METT5D1 MTCH2 NADK NCOA1 NDUFS3 PTPN23 PTRHD1 SMARCD1 SRR TEAD3 Y_RNA
Smoking Status 1.90 8 2 6.1 -0.62 1.0e-01 CADM2 LIN7C MAP2K5 MTCH2 PTPN23 RASSF1 SH3YL1 SRR
Allergy or Eczema 1.17 7 1 3.0 0.59 1.6e-01 CALCRL GGNBP2 MAP3K11 NEGR1 NHP2L1 SH2B1 SRR
Cardiovascular Disease 1.72 14 6 18.2 -0.30 2.7e-01 ACP2 ATG7 C18orf8 CALCRL FUT2 GPR153 MADD MAP2K5 MECR NCOA1 NEGR1 RP11-347C12.2 SMARCD1 UHRF1BP1
Hypothyroidism (self reported) 1.37 3 1 3.0 0.00 1.0e+00 C1QTNF4 MADD UHRF1BP1
Respiratory disease 0.91 1 0 0.0 0.00 1.0e+00 NHP2L1
Type 2 Diabetes (T2D) 1.72 4 0 0.0 -1.00 5.3e-04 AKTIP C1QTNF4 NDUFS3 Y_RNA
Lung FEV1/FVC ratio 1.34 16 10 30.3 -0.66 2.7e-03 ADCY3 ATP6V0D1 CALCRL DNAJC27 FUT2 GPR153 HDGFRP3 NCOA1 NEGR1 PINX1 PM20D1 PTRHD1 RP11-347C12.2 SLC25A17 SREK1IP1 TTC26
Lung FVC 1.56 20 9 27.3 0.09 6.9e-01 ATP6V0D1 BCDIN3D C3orf38 CERS5 DOT1L FLT3 HDGFRP3 IGHMBP2 LIMA1 LIN28B LIN7C MADD MAP2K5 NCOA1 NLRC3 RASSF1 RP11-347C12.2 SH2B1 ST7L UHRF1BP1
Neuroticism 2.15 11 4 12.1 0.91 3.5e-06 C1QTNF4 CADM2 CTC-498M16.2 DNPH1 FAM120AOS MADD MAP2K5 MTCH2 NDUFS3 NHP2L1 Y_RNA
Chronotype (morning person) 1.87 7 2 6.1 -0.50 2.5e-01 ADCY3 AKTIP FTO FUT2 MADD NDUFS3 RBL2
Hair Pigment 0.29 13 9 27.3 -0.14 6.3e-01 ACP2 ADCY3 C11orf24 DNAJC27 HDGFRP3 IGHMBP2 KANSL1 LMBR1L MADD PM20D1 PPM1F RIT1 RP11-386G11.10
Tanning 0.31 6 5 15.2 0.67 7.2e-02 ADCY3 C1QTNF4 CADM2 DNAJC27 IGHMBP2 POMC
Hand grip strength (left) 2.82 17 12 36.4 -0.69 1.9e-04 ADCY3 C1QTNF4 CADM2 DNAJC27 DOT1L GPRC5B LIN28B MADD MTCH2 NCOA1 NDUFS3 PINX1 PM20D1 PTRHD1 RP11-347C12.2 Y_RNA ZNF781
Number of treatments/medications taken 1.27 1 0 0.0 0.00 1.0e+00 LIN28B
Sensitivity / hurt feelings 2.46 7 3 9.1 -0.99 3.5e-07 AF131215.2 AF131215.9 AF131216.5 CLDN23 MFHAS1 TDH TMEM161A
Frequency of depressed mood in last 2 weeks 2.19 4 1 3.0 -0.38 6.2e-01 AF131215.2 FAM120AOS MADD MTCH2
Relative age of first facial hair 1.80 5 3 9.1 -0.90 3.6e-02 ATG7 C18orf8 ETAA1 LIN28B TTC26
Ever used hormone-replacement therapy (HRT) 1.91 1 0 0.0 0.00 1.0e+00 BCDIN3D
Systolic blood pressure, automated reading 2.01 14 9 27.3 -0.04 8.7e-01 AF131215.2 AF131215.9 AF131216.5 ATG7 C1QTNF4 CLDN23 FAM85A MADD MFHAS1 NADK NCOA1 SMARCD1 SRR TEAD3
Medication: Metformin 2.24 3 1 3.0 -0.97 3.1e-02 C1QTNF4 NDUFS3 Y_RNA
Pack years adult smoking proportion 1.41 1 0 0.0 0.00 1.0e+00 SH2B1
Impedance of leg (right) 5.90 73 53 160.6 -0.90 5.6e-31 ACP2 ACSM5 ADCY3 ADCY9 AF131215.2 AF131215.9 AF131216.5 AKTIP AL137059.1 ARMC6 ATG7 ATXN7L2 C11orf24 C1QTNF4 CADM2 CERS5 CLDN23 CLOCK DNAJC27 DTX2P1-UPK3BP1-PMS2P11 FAIM2 FAM120AOS FAM85A FRS3 FTO GPRC5B HAPLN4 IGHMBP2 LIMA1 LIN28B LIN7C LMBR1L MADD MAP2K5 MAP3K11 MC4R MECR METTL21A MFHAS1 NADK NEGR1 NLRC3 ORAOV1 PINX1 PM20D1 POLK POMC PPM1F PTPN23 RASAL2-AS1 RASSF1 RBL2 RIT1 RP11-347C12.2 RP11-386G11.10 RP11-568K15.1 SAE1 SEC16B SH2B1 SH3YL1 SLC25A17 SMARCD1 SREK1IP1 SRR TDH TEAD3 TFAP2D TMEM127 TMEM161A TMEM18 TTC26 TYW3 UHRF1BP1
Leg fat-free mass (left) 4.58 57 45 136.4 0.86 1.2e-19 ACSM5 ADCY9 AF131215.2 AF131215.9 AKTIP AL137059.1 C11orf24 C12orf62 C18orf8 C3orf38 CADM2 CERS5 CTC-498M16.2 DOT1L DTX2P1-UPK3BP1-PMS2P11 FAIM2 FAM85A FLT3 FRS3 FTO GGNBP2 GPRC5B IGHMBP2 KANSL1 LIN28B LIN7C MAP2K5 MC4R METTL21A MFHAS1 MTIF3 NADK NCOA1 NEGR1 NLRC3 ORAOV1 PIK3C3 PM20D1 POLK RASAL2-AS1 RASSF1 RBL2 RP11-347C12.2 RP11-568K15.1 SAE1 SEC16B SH2B1 SLC25A17 SRR SSBP3 TEAD3 TFAP2D TM2D1 TMEM161A TMEM18 TTC26 UHRF1BP1
Trunk fat percentage 5.49 35 29 87.9 0.90 2.0e-16 ACP2 ADCY3 ADCY9 AKTIP AL137059.1 C12orf62 C18orf8 C1QTNF4 C3orf38 CERS5 DNAJC27 DTX2P1-UPK3BP1-PMS2P11 FAIM2 FTO GGNBP2 LIN7C MADD MAP2K5 MC4R MTCH2 NDUFS3 NEGR1 PIK3C3 POLK POMC PTRHD1 RASAL2-AS1 RBL2 RP11-347C12.2 SH2B1 SRR ST7L TM2D1 UHRF1BP1 Y_RNA
Hand grip strength (right) 2.24 15 10 30.3 -0.78 5.9e-05 ADCY3 C1QTNF4 DNAJC27 DOT1L LIN28B MADD MTCH2 NCOA1 NDUFS3 PM20D1 PTRHD1 RP11-347C12.2 SH2B1 Y_RNA ZNF781
Townsend deprivation index at recruitment 2.17 2 0 0.0 0.00 1.0e+00 MAP2K5 MYO18A
Current tobacco smoking 2.54 8 0 0.0 0.11 7.8e-01 AF131215.2 AF131216.5 C1QTNF4 FAM85A MFHAS1 MTCH2 TDH Y_RNA
Maternal smoking around birth 1.44 2 0 0.0 0.00 1.0e+00 GGNBP2 LIN7C
Fed-up feelings 2.06 8 2 6.1 -0.61 6.2e-02 AF131215.2 AF131215.9 C11orf80 C1QTNF4 CLDN23 MADD MFHAS1 SH2B1
Frequency of unenthusiasm / disinterest in last 2 weeks 1.63 1 0 0.0 0.00 1.0e+00 FAM120AOS
Relative age voice broke 1.69 1 1 3.0 0.00 1.0e+00 LIN28B
Taking other prescription medications 1.44 1 0 0.0 0.00 1.0e+00 UHRF1BP1
Age when periods started (menarche) 4.76 25 13 39.4 -0.81 1.4e-08 ADCY3 AKTIP C1QTNF4 C3orf38 DNAJC27 FAIM2 FPGT FTO GPRC5B HAPLN4 LEPR LIN28B MADD MAP2K5 MTCH2 NDUFS3 NEGR1 PAN3-AS1 RASAL2-AS1 RBL2 RP11-568K15.1 SSBP3 TTC26 TYW3 Y_RNA
Heel bone mineral density (BMD) T-score, automated (left) 3.35 14 9 27.3 0.94 5.0e-09 ADCY9 AF131215.2 AF131215.9 AF131216.5 C11orf24 CERS5 CLDN23 FAM85A IGHMBP2 LIN28B MFHAS1 PINX1 ST7L TDH
High blood pressure 2.36 17 10 30.3 0.07 7.8e-01 ACP2 AF131215.2 AF131215.9 AF131216.5 ATG7 FAM85A FUT2 GPR153 MADD MAP2K5 MECR MFHAS1 NCOA1 NEGR1 RP11-347C12.2 SMARCD1 SRR
Hayfever, allergic rhinitis or eczema 1.17 3 1 3.0 0.00 1.0e+00 MAP3K11 NEGR1 NHP2L1
Multivitamins +/- minerals 1.60 1 0 0.0 0.00 1.0e+00 PM20D1
Medication: Levothyroxine sodium 1.75 4 0 0.0 0.23 7.7e-01 FAM85A MFHAS1 SAE1 UHRF1BP1
Sitting height 2.59 25 19 57.6 -0.80 2.0e-08 ACP2 ADCY3 AL137059.1 C1QTNF4 CALCRL CMIP DNAJC27 DOT1L FAM228B FRS3 FUT2 GPR153 HAPLN4 MADD MTCH2 NCOA1 NDUFS3 PM20D1 POMC PTRHD1 SMARCD1 TM2D1 TP53I3 UHRF1BP1 Y_RNA
Body mass index (BMI) 8.37 71 57 172.7 0.95 1.2e-46 ACP2 ACSM5 ADCY3 ADCY9 AF131215.2 AF131215.9 AF131216.5 AKTIP AL137059.1 C12orf62 C18orf8 C1QTNF4 C3orf38 CADM2 CERS5 CLDN23 CTC-498M16.2 DNAJC27 DTX2P1-UPK3BP1-PMS2P11 FAIM2 FAM228B FAM85A FLT3 FRS3 FTO GGNBP2 GPR153 GPRC5B HAPLN4 IGHMBP2 LIN7C MADD MAP2K5 MC4R METTL21A MFHAS1 MTCH2 MTIF3 NADK NCOA1 NDUFS3 NEGR1 NLRC3 ORAOV1 PIK3C3 PINX1 POLK POMC PTPN23 PTRHD1 RASA2 RASAL2-AS1 RASSF1 RBL2 RP11-347C12.2 RP11-568K15.1 SAE1 SEC16B SH2B1 SH3YL1 SLC25A17 SRR TDH TEAD3 TFAP2D TM2D1 TMEM18 TTC26 TYW3 UHRF1BP1 Y_RNA
Impedance of leg (left) 5.91 76 55 166.7 -0.89 1.9e-30 ACP2 ACSM5 ADAM23 ADCY3 ADCY9 AF131215.2 AF131215.9 AF131216.5 AKTIP AL137059.1 ARMC6 ATG7 ATXN7L2 C11orf24 CADM2 CERS5 CLDN23 CLOCK DNAJC16 DNAJC27 DTX2P1-UPK3BP1-PMS2P11 FAIM2 FAM120AOS FAM85A FRS3 FTO GPRC5B HAPLN4 IGHMBP2 LIMA1 LIN28B LIN7C LINC00476 LMBR1L MADD MAP2K5 MAP3K11 MC4R MECR METTL21A MFHAS1 MTIF3 NADK NEGR1 NLRC3 ORAOV1 PINX1 PM20D1 POLK POMC PPM1F PTPN23 RASAL2-AS1 RASSF1 RBL2 RIT1 RP11-347C12.2 RP11-386G11.10 RP11-568K15.1 SAE1 SEC16B SH2B1 SH3YL1 SLC25A17 SMARCD1 SREK1IP1 SRR TDH TEAD3 TFAP2D TMEM127 TMEM161A TMEM18 TTC26 TYW3 UHRF1BP1
Leg predicted mass (left) 4.56 56 45 136.4 0.85 1.3e-19 ACSM5 ADCY9 AF131215.2 AF131215.9 AKTIP AL137059.1 C11orf24 C12orf62 C18orf8 C3orf38 CADM2 CERS5 CTC-498M16.2 DOT1L DTX2P1-UPK3BP1-PMS2P11 FAIM2 FAM85A FLT3 FRS3 FTO GGNBP2 GPRC5B IGHMBP2 KANSL1 LIN28B LIN7C MAP2K5 MC4R METTL21A MFHAS1 MTIF3 NADK NCOA1 NEGR1 NLRC3 ORAOV1 PM20D1 POLK RASAL2-AS1 RASSF1 RBL2 RP11-347C12.2 RP11-568K15.1 SAE1 SEC16B SH2B1 SLC25A17 SRR SSBP3 TEAD3 TFAP2D TM2D1 TMEM161A TMEM18 TTC26 UHRF1BP1
Trunk fat mass 5.55 46 32 97.0 0.89 2.6e-20 ACP2 ADCY3 ADCY9 AKTIP AL137059.1 C12orf62 C18orf8 C1QTNF4 C3orf38 CERS5 CTC-498M16.2 DNAJC27 DTX2P1-UPK3BP1-PMS2P11 FAIM2 FLT3 FRS3 FTO GGNBP2 GPRC5B KANSL1 LIN28B LIN7C MADD MAP2K5 MC4R MTCH2 MTIF3 NDUFS3 NEGR1 NLRC3 PIK3C3 POLK POMC RASAL2-AS1 RBL2 RP11-347C12.2 RP11-568K15.1 SAE1 SEC16B SH2B1 SRR ST7L TM2D1 TMEM18 UHRF1BP1 Y_RNA
Waist circumference 5.99 49 36 109.1 0.92 3.4e-25 ADCY3 ADCY9 AKTIP AL137059.1 C12orf62 C18orf8 C1QTNF4 C3orf38 CADM2 CALCRL CERS5 CTC-498M16.2 DNAJC27 DTX2P1-UPK3BP1-PMS2P11 FAIM2 FLT3 FRS3 FTO GGNBP2 GPR153 GPRC5B KANSL1 LIN7C MADD MAP2K5 MC4R METTL21A MTCH2 NADK NDUFS3 NEGR1 PIK3C3 POLK POMC RASA2 RASAL2-AS1 RBL2 RP11-347C12.2 RP11-568K15.1 SAE1 SEC16B SH2B1 SRR TEAD3 TFAP2D TM2D1 TMEM18 UHRF1BP1 Y_RNA
Number of incorrect matches in round 1.39 1 1 3.0 0.00 1.0e+00 RP11-347C12.2
Past tobacco smoking 2.04 7 2 6.1 -0.83 1.1e-02 ADCY3 C18orf8 CADM2 MAP2K5 PTPN23 SH3YL1 TMEM18
Alcohol usually taken with meals 1.56 1 0 0.0 0.00 1.0e+00 NEGR1
Nervous feelings 3.96 13 10 30.3 -0.98 1.0e-11 AF131215.2 AF131215.9 AF131216.5 CADM2 CLDN23 CTC-498M16.2 FAM85A LIN7C MADD MFHAS1 PINX1 RASSF1 TDH
Frequency of tenseness / restlessness in last 2 weeks 1.44 1 0 0.0 0.00 1.0e+00 FAM120AOS
Hearing difficulty/problems with background noise 1.38 3 0 0.0 0.00 1.0e+00 C1QTNF4 LIN28B PM20D1
Had menopause 1.15 1 0 0.0 0.00 1.0e+00 FGFR4
Forced vital capacity (FVC) 2.40 17 11 33.3 -0.87 7.5e-08 ACP2 ADCY3 BCDIN3D C1QTNF4 CLDN23 CMIP DNAJC27 KANSL1 MADD MTCH2 NCOA1 NDUFS3 NFATC1 NLRC3 POMC PTRHD1 Y_RNA
Heel bone mineral density (BMD) T-score, automated (right) 3.36 14 10 30.3 0.97 4.8e-11 AF131215.2 AF131215.9 AF131216.5 ATG7 C11orf24 C12orf62 CERS5 CLDN23 FAM85A IGHMBP2 MFHAS1 PINX1 ST7L TDH
Qualifications: None of the above 1.34 6 4 12.1 0.03 9.5e-01 BCDIN3D CTC-498M16.2 GGNBP2 NEGR1 PTPN23 SH2B1
Financial difficulties in last 2 years 1.36 1 0 0.0 0.00 1.0e+00 FGFR4
Allergy 1.03 2 1 3.0 0.00 1.0e+00 MAP3K11 NHP2L1
Pain all over the body in last month 1.22 1 0 0.0 0.00 1.0e+00 C11orf80
Diabetes (self-reported) 1.61 2 0 0.0 0.00 1.0e+00 NLRC3 POLK
Medication: Simvastatin 1.40 2 0 0.0 0.00 1.0e+00 FUT2 GPR153
Fluid intelligence score 1.88 8 4 12.1 -0.61 8.3e-02 C1QTNF4 GGNBP2 MADD MTCH2 NDUFS3 NEGR1 SH2B1 Y_RNA
Neuroticism score 4.01 16 11 33.3 -0.96 2.2e-12 AF131215.2 AF131215.9 AF131216.5 C1QTNF4 CADM2 CLDN23 FAM120AOS FAM85A MADD MC4R MFHAS1 MTCH2 NHP2L1 PINX1 TDH Y_RNA
Weight 5.30 59 46 139.4 0.89 2.8e-25 ACSM5 ADCY3 ADCY9 AF131215.2 AF131215.9 AKTIP AL137059.1 C11orf24 C12orf62 C18orf8 C1QTNF4 C3orf38 CADM2 CERS5 CTC-498M16.2 DNAJC27 DOT1L DTX2P1-UPK3BP1-PMS2P11 FAIM2 FAM85A FLT3 FRS3 FTO GGNBP2 GPRC5B IGHMBP2 KANSL1 LIN7C MADD MAP2K5 MC4R METTL21A MFHAS1 MTIF3 NADK NDUFS3 NEGR1 NLRC3 ORAOV1 PIK3C3 PM20D1 POLK POMC RASA2 RASAL2-AS1 RASSF1 RBL2 RP11-347C12.2 RP11-568K15.1 SAE1 SEC16B SH2B1 SRR SSBP3 TEAD3 TFAP2D TM2D1 TMEM18 UHRF1BP1
Impedance of arm (right) 4.30 52 38 115.2 -0.90 7.6e-22 ACSM5 ADAM23 AF131215.2 AF131215.9 AF131216.5 AKTIP C11orf24 CADM2 CERS5 CTC-498M16.2 DTX2P1-UPK3BP1-PMS2P11 FAIM2 FAM85A FTO GGNBP2 GPRC5B HAPLN4 HDLBP IGHMBP2 LIMA1 LIN28B LIN7C LINC00476 LMBR1L MAP2K5 MAP3K11 MC4R METTL21A MFHAS1 NADK NEGR1 NHP2L1 NLRC3 PINX1 PM20D1 POLK RASSF1 RBL2 RP11-347C12.2 RP11-568K15.1 SAE1 SH3YL1 SLC25A17 SMARCD1 SREK1IP1 ST7L TDH TEAD3 TFAP2D TMEM18 TTC26 UHRF1BP1
Arm fat percentage (right) 7.77 54 35 106.1 0.93 1.8e-30 ACP2 ACSM5 ADCY3 ADCY9 AF131215.2 AKTIP AL137059.1 C12orf62 C18orf8 C1QTNF4 C3orf38 CERS5 CTC-498M16.2 DNAJC27 DTX2P1-UPK3BP1-PMS2P11 FAIM2 FAM85A FLT3 FTO GGNBP2 GPR153 GPRC5B KANSL1 LIN7C MADD MAP2K5 MC4R MFHAS1 MTCH2 MTIF3 NCOA1 NDUFS3 NEGR1 NFATC1 NLRC3 ORAOV1 PIK3C3 POLK POMC PTRHD1 RASAL2-AS1 RASSF1 RBL2 RP11-347C12.2 RP11-568K15.1 SAE1 SEC16B SH2B1 SRR TM2D1 TMEM18 TYW3 UHRF1BP1 Y_RNA
Trunk fat-free mass 3.41 54 39 118.2 0.53 1.3e-05 ACSM5 ADCY9 AF131215.2 AF131215.9 AKTIP AL137059.1 C11orf24 C12orf62 C18orf8 C1QTNF4 C3orf38 CADM2 CERS5 CTC-498M16.2 DOT1L DTX2P1-UPK3BP1-PMS2P11 FAIM2 FGFR4 FLT3 FRS3 FTO GPRC5B IGHMBP2 KANSL1 LIN28B LIN7C MC4R METTL21A MTCH2 MTIF3 NADK NCOA1 NDUFS3 NEGR1 ORAOV1 PINX1 PM20D1 POLK PTRHD1 RASAL2-AS1 RASSF1 RBL2 RP11-347C12.2 RP11-568K15.1 SAE1 SEC16B SH2B1 SLC25A17 TEAD3 TM2D1 TMEM18 TP53I3 UHRF1BP1 Y_RNA
Hip circumference 5.61 56 41 124.2 0.91 9.0e-26 ACP2 ACSM5 ADCY3 ADCY9 AF131215.2 AF131215.9 AKTIP AL137059.1 C12orf62 C18orf8 C1QTNF4 C3orf38 CADM2 CERS5 CTC-498M16.2 DNAJC27 DOT1L DTX2P1-UPK3BP1-PMS2P11 FAIM2 FAM85A FLT3 FRS3 FTO GGNBP2 GPRC5B LIN7C MADD MAP2K5 MC4R METTL21A MTCH2 MTIF3 NADK NDUFS3 NEGR1 NLRC3 ORAOV1 PIK3C3 POLK POMC RASA2 RASAL2-AS1 RASSF1 RBL2 RP11-347C12.2 RP11-568K15.1 SAE1 SEC16B SH2B1 SRR TEAD3 TFAP2D TM2D1 TMEM18 UHRF1BP1 Y_RNA
Alcohol intake versus 10 years previously 1.38 1 0 0.0 0.00 1.0e+00 NEGR1
Father's age at death 1.59 1 0 0.0 0.00 1.0e+00 FAM85A
Worrier / anxious feelings 4.05 13 9 27.3 -0.89 1.9e-06 ADCY9 AF131215.2 AF131215.9 AF131216.5 CADM2 CLDN23 DNPH1 FAM85A MC4R MFHAS1 PINX1 TDH TEAD3
Frequency of tiredness / lethargy in last 2 weeks 1.82 5 0 0.0 -0.64 1.7e-01 FAM120AOS LIN7C MTCH2 RP11-165J3.6 SREK1IP1
Forced expiratory volume in 1-second (FEV1) 2.06 13 10 30.3 -0.89 1.3e-06 ADCY3 C1QTNF4 CLDN23 CMIP DNAJC27 HDGFRP3 MADD MFHAS1 MTCH2 NCOA1 NDUFS3 NLRC3 Y_RNA
Qualifications: A levels/AS levels or equivalent 1.13 1 1 3.0 0.00 1.0e+00 NEGR1
Mouth/teeth dental problems: Dentures 1.76 4 0 0.0 0.47 4.3e-01 ADCY3 AF131215.2 BCDIN3D FUT2
Asthma 1.22 1 0 0.0 0.00 1.0e+00 NHP2L1
Medication: Cholesterol lowering 1.35 2 0 0.0 0.00 1.0e+00 GPR153 TMEM161A
Illnesses of mother 1.23 1 0 0.0 0.00 1.0e+00 GGNBP2
Forced expiratory volume in 1-second (FEV1), Best measure 2.01 13 10 30.3 -0.85 1.3e-05 ACP2 ADCY3 C1QTNF4 CLDN23 CMIP DNAJC27 MADD MFHAS1 MTCH2 NCOA1 NDUFS3 NLRC3 Y_RNA
Impedance of arm (left) 4.22 50 36 109.1 -0.90 8.2e-21 ACSM5 ADAM23 AF131215.2 AF131215.9 AF131216.5 AKTIP C11orf24 C18orf8 CADM2 CERS5 CTC-498M16.2 DTX2P1-UPK3BP1-PMS2P11 FAIM2 FAM85A FTO GGNBP2 GPRC5B HAPLN4 HDLBP IGHMBP2 LIMA1 LIN28B LIN7C LINC00476 MAP2K5 MAP3K11 MC4R METTL21A MFHAS1 NADK NEGR1 NHP2L1 NLRC3 PINX1 PM20D1 POLK RASSF1 RBL2 RP11-347C12.2 RP11-568K15.1 SAE1 SEC16B SH3YL1 SLC25A17 SMARCD1 TDH TEAD3 TMEM18 TTC26 UHRF1BP1
Arm fat mass (right) 7.32 62 52 157.6 0.95 1.2e-38 ACP2 ACSM5 ADCY3 ADCY9 AF131215.2 AF131215.9 AKTIP AL137059.1 C12orf62 C18orf8 C1QTNF4 C3orf38 CADM2 CERS5 CLDN23 CTC-498M16.2 DNAJC27 DTX2P1-UPK3BP1-PMS2P11 FAIM2 FAM85A FLT3 FRS3 FTO GGNBP2 GPR153 GPRC5B KANSL1 LIN7C MADD MAP2K5 MC4R METTL21A MFHAS1 MTCH2 MTIF3 NADK NDUFS3 NEGR1 NLRC3 ORAOV1 PIK3C3 POLK POMC PTRHD1 RASA2 RASAL2-AS1 RASSF1 RBL2 RP11-347C12.2 RP11-568K15.1 SAE1 SEC16B SH2B1 SRR SSBP3 TEAD3 TFAP2D TM2D1 TMEM18 TYW3 UHRF1BP1 Y_RNA
Trunk predicted mass 3.42 53 39 118.2 0.52 2.0e-05 ADCY9 AF131215.2 AF131215.9 AKTIP AL137059.1 C11orf24 C12orf62 C18orf8 C1QTNF4 C3orf38 CADM2 CERS5 CTC-498M16.2 DOT1L DTX2P1-UPK3BP1-PMS2P11 FAIM2 FGFR4 FLT3 FRS3 FTO GPRC5B IGHMBP2 KANSL1 LIN28B LIN7C MC4R METTL21A MTCH2 MTIF3 NADK NCOA1 NDUFS3 NEGR1 ORAOV1 PINX1 PM20D1 POLK PTRHD1 RASAL2-AS1 RASSF1 RBL2 RP11-347C12.2 RP11-568K15.1 SAE1 SEC16B SH2B1 SLC25A17 TEAD3 TM2D1 TMEM18 TP53I3 UHRF1BP1 Y_RNA
Standing height 2.78 36 29 87.9 -0.72 5.8e-09 ACP2 ADCY3 ADCY9 AF131215.2 C1QTNF4 CLDN23 CMIP DNAJC27 DOT1L FAM85A FGFR4 FRS3 FUT2 HAPLN4 KANSL1 LIN28B LINC00476 MADD MAP3K11 MC4R MFHAS1 MTCH2 NCOA1 NDUFS3 PM20D1 POMC PTPN23 PTRHD1 RASSF1 SEC23IP SH2B1 SMARCD1 TM2D1 TP53I3 UHRF1BP1 Y_RNA
Tense / 'highly strung' 2.72 6 4 12.1 -0.30 4.8e-01 AF131215.2 AF131215.9 CADM2 FAM120AOS FAM85A MFHAS1
Seen doctor (GP) for nerves, anxiety, tension or depression 1.98 1 1 3.0 0.00 1.0e+00 NEGR1
Hair/balding pattern: Pattern 4 1.45 6 4 12.1 0.84 3.5e-02 CERS5 ETAA1 KANSL1 LIMA1 SMARCD1 SRR
Peak expiratory flow (PEF) 2.06 9 4 12.1 -0.75 7.4e-03 AF131215.2 CLDN23 FAM85A HDGFRP3 MFHAS1 NCOA1 NDUFS3 PM20D1 Y_RNA
Headache pain in last month 1.38 2 0 0.0 0.00 1.0e+00 MAP2K5 MFHAS1
Medication for cholesterol, blood pressure or diabetes 1.47 2 0 0.0 0.00 1.0e+00 AKTIP GPR153
Gout (self-reported) 0.92 1 1 3.0 0.00 1.0e+00 MAP3K11
Hypothyroidism/myxoedema (self-reported) 1.99 6 3 9.1 -0.66 1.1e-01 AF131215.2 AF131215.9 AF131216.5 FAM85A MFHAS1 UHRF1BP1
Birth weight 1.92 9 1 3.0 -0.02 9.5e-01 ADCY9 C1QTNF4 MTCH2 NDUFS3 ORAOV1 PLA2R1 RIT1 SRR Y_RNA
Forced vital capacity (FVC), Best measure 2.36 14 12 36.4 -0.86 6.7e-07 ACP2 ADCY3 BCDIN3D C1QTNF4 CMIP DNAJC27 MADD MTCH2 NCOA1 NDUFS3 NFATC1 NLRC3 PTRHD1 Y_RNA
Body fat percentage 6.19 40 29 87.9 0.91 4.5e-20 ACP2 ADCY3 ADCY9 AKTIP AL137059.1 C12orf62 C18orf8 C1QTNF4 C3orf38 CERS5 CTC-498M16.2 DNAJC27 DTX2P1-UPK3BP1-PMS2P11 FAIM2 FTO GGNBP2 GPR153 LIN7C MADD MAP2K5 MC4R MTCH2 MTIF3 NCOA1 NDUFS3 NEGR1 NLRC3 PIK3C3 POLK POMC PTRHD1 RASAL2-AS1 RBL2 RP11-347C12.2 SH2B1 SRR ST7L TM2D1 UHRF1BP1 Y_RNA
Leg fat percentage (right) 5.95 41 28 84.8 0.94 2.7e-25 ACP2 ADCY3 AF131215.2 AKTIP AL137059.1 C12orf62 C18orf8 C1QTNF4 C3orf38 CALCRL CERS5 CTC-498M16.2 DNAJC27 DTX2P1-UPK3BP1-PMS2P11 FAIM2 FAM228B FAM85A FTO GGNBP2 GPR153 LIN7C MADD MAP2K5 MC4R MTCH2 MTIF3 NCOA1 NDUFS3 NEGR1 NLRC3 PIK3C3 POLK POMC PTRHD1 RASAL2-AS1 RBL2 RP11-347C12.2 SH2B1 TM2D1 UHRF1BP1 Y_RNA
Arm fat-free mass (right) 3.85 53 41 124.2 0.75 8.4e-12 ACSM5 ADCY9 AF131215.2 AF131215.9 AKTIP AL137059.1 C11orf24 C12orf62 C18orf8 C1QTNF4 C3orf38 CADM2 CERS5 CTC-498M16.2 DOT1L DTX2P1-UPK3BP1-PMS2P11 FAIM2 FAM85A FGFR4 FLT3 FRS3 FTO GPRC5B IGHMBP2 LIN7C MAP2K5 MC4R METTL21A MFHAS1 MTCH2 MTIF3 NADK NCOA1 NEGR1 ORAOV1 PINX1 PM20D1 POLK RASAL2-AS1 RASSF1 RBL2 RP11-347C12.2 RP11-568K15.1 SAE1 SEC16B SH2B1 SH3YL1 SLC25A17 TEAD3 TM2D1 TMEM18 TTC26 UHRF1BP1
Exposure to tobacco smoke outside home 1.06 1 0 0.0 0.00 1.0e+00 LIN7C
Worry too long after embarrassment 2.76 8 3 9.1 -0.80 3.0e-03 AF131215.2 AF131215.9 AF131216.5 BCDIN3D CLDN23 FAM85A MFHAS1 TDH
Wheeze or whistling in the chest in last year 1.47 2 0 0.0 0.00 1.0e+00 LIN7C RP11-347C12.2
Number of children fathered 1.33 1 0 0.0 0.00 1.0e+00 CADM2
Reason for reducing amount of alcohol drunk: Health precaution 1.73 1 0 0.0 0.00 1.0e+00 CTC-498M16.2
Age at first live birth 1.40 1 0 0.0 0.00 1.0e+00 AF131215.2
Qualifications: College or University degree 1.29 7 4 12.1 0.02 9.6e-01 BCDIN3D C18orf8 CTC-498M16.2 GGNBP2 NEGR1 PTPN23 SH2B1
Medication: Blood pressure 1.92 1 1 3.0 0.00 1.0e+00 GPR153
Medication: Allopurinol 1.11 1 0 0.0 0.00 1.0e+00 MAP3K11
Mean time to correctly identify matches 1.63 5 2 6.1 -0.43 4.7e-01 ADCY3 C1QL4 KANSL1 PM20D1 TP53I3
Whole body fat mass 6.22 55 33 100.0 0.93 4.8e-29 ACP2 ACSM5 ADCY3 ADCY9 AF131215.2 AF131215.9 AKTIP AL137059.1 C12orf62 C18orf8 C1QTNF4 C3orf38 CADM2 CERS5 CTC-498M16.2 DNAJC27 DTX2P1-UPK3BP1-PMS2P11 FAIM2 FAM85A FLT3 FRS3 FTO GGNBP2 GPR153 GPRC5B KANSL1 LIN7C MADD MAP2K5 MC4R METTL21A MFHAS1 MTCH2 MTIF3 NDUFS3 NEGR1 NLRC3 PIK3C3 POLK POMC PTRHD1 RASA2 RASAL2-AS1 RBL2 RP11-347C12.2 RP11-568K15.1 SAE1 SEC16B SH2B1 SRR TEAD3 TM2D1 TMEM18 UHRF1BP1 Y_RNA
Leg fat mass (right) 6.78 55 41 124.2 0.93 8.6e-32 ACP2 ACSM5 ADCY3 ADCY9 AF131215.2 AF131215.9 AKTIP AL137059.1 C12orf62 C18orf8 C1QTNF4 C3orf38 CADM2 CALCRL CERS5 CTC-498M16.2 DNAJC27 DTX2P1-UPK3BP1-PMS2P11 FAIM2 FAM85A FLT3 FTO GGNBP2 GPR153 GPRC5B LIN7C MADD MAP2K5 MC4R METTL21A MFHAS1 MTCH2 MTIF3 NADK NDUFS3 NEGR1 NLRC3 PIK3C3 POLK POMC PTRHD1 RASA2 RASAL2-AS1 RASSF1 RBL2 RP11-347C12.2 RP11-568K15.1 SAE1 SEC16B SH2B1 TEAD3 TM2D1 TMEM18 UHRF1BP1 Y_RNA
Arm predicted mass (right) 3.86 52 40 121.2 0.75 1.1e-11 ACSM5 ADCY9 AF131215.2 AF131215.9 AKTIP AL137059.1 C11orf24 C12orf62 C18orf8 C1QTNF4 C3orf38 CADM2 CERS5 CTC-498M16.2 DOT1L DTX2P1-UPK3BP1-PMS2P11 FAIM2 FAM85A FGFR4 FLT3 FRS3 FTO GGNBP2 GPRC5B IGHMBP2 LIN7C MAP2K5 MC4R METTL21A MFHAS1 MTCH2 MTIF3 NADK NCOA1 NEGR1 PINX1 PM20D1 POLK RASAL2-AS1 RASSF1 RBL2 RP11-347C12.2 RP11-568K15.1 SAE1 SEC16B SH2B1 SLC25A17 TEAD3 TM2D1 TMEM18 TTC26 UHRF1BP1
Pulse rate, automated reading 1.31 12 4 12.1 -0.13 6.8e-01 CALCRL CTC-498M16.2 GPRC5B HDGFRP3 IGHMBP2 LMBR1L NEGR1 NFATC1 PM20D1 PTPN23 RASSF1 TMEM127
Alcohol intake frequency. 2.66 13 11 33.3 0.79 3.0e-04 C18orf8 C1QTNF4 CADM2 CTC-498M16.2 FUT2 MADD MTCH2 MYO18A NDUFS3 NEGR1 RP11-347C12.2 SH2B1 Y_RNA
Comparative height size at age 10 2.12 24 17 51.5 -0.40 2.8e-02 ADCY3 ADCY9 BCDIN3D C18orf8 C1QTNF4 CMIP DNAJC27 DOT1L FAIM2 FGFR4 FRS3 FUT2 MTCH2 NCOA1 NDUFS3 PM20D1 POMC PTRHD1 RASAL2-AS1 SH2B1 TM2D1 TMEM18 TP53I3 Y_RNA
Suffer from 'nerves' 4.20 15 11 33.3 -0.87 2.6e-07 ACP2 AF131215.2 AF131215.9 C1QTNF4 CADM2 CLDN23 CTC-498M16.2 MADD MC4R MFHAS1 MTCH2 NDUFS3 PINX1 SH2B1 Y_RNA
Overall health rating 1.53 3 0 0.0 0.00 1.0e+00 FAM120AOS RP11-165J3.6 UHRF1BP1
Commuting to job workplace: Car/motor vehicle 1.14 1 0 0.0 0.00 1.0e+00 NEGR1
Hypertension (Self-reported) 2.35 18 9 27.3 0.16 4.7e-01 ACP2 AF131215.2 AF131215.9 AF131216.5 ATG7 CALCRL CLOCK FAM85A FUT2 GPR153 MADD MAP2K5 MECR MFHAS1 NCOA1 NEGR1 SMARCD1 SRR
Smoking status: Previous 1.76 4 1 3.0 0.23 7.7e-01 C18orf8 CADM2 MAP2K5 TMEM18
Forced expiratory volume in 1-second (FEV1), predicted 2.05 11 1 3.0 -0.80 1.9e-03 ADCY3 C1QTNF4 DNAJC27 DOT1L FRS3 LIN28B MTCH2 NCOA1 NDUFS3 RASSF1 Y_RNA
Whole body fat-free mass 3.83 56 42 127.3 0.74 2.9e-12 ACSM5 ADCY9 AF131215.2 AF131215.9 AKTIP AL137059.1 C11orf24 C12orf62 C18orf8 C1QTNF4 C3orf38 CADM2 CERS5 CTC-498M16.2 DOT1L DTX2P1-UPK3BP1-PMS2P11 FAIM2 FAM85A FGFR4 FLT3 FRS3 FTO GPRC5B IGHMBP2 KANSL1 LIN28B LIN7C MAP2K5 MC4R METTL21A MFHAS1 MTCH2 MTIF3 NADK NCOA1 NEGR1 ORAOV1 PINX1 PM20D1 POLK RASAL2-AS1 RASSF1 RBL2 RP11-347C12.2 RP11-568K15.1 SAE1 SEC16B SH2B1 SLC25A17 TEAD3 TFAP2D TM2D1 TMEM161A TMEM18 TTC26 UHRF1BP1
Leg fat-free mass (right) 4.40 56 44 133.3 0.85 6.2e-19 ACSM5 ADCY9 AF131215.2 AF131215.9 AKTIP AL137059.1 ARMC6 C11orf24 C12orf62 C18orf8 C3orf38 CADM2 CERS5 CTC-498M16.2 DOT1L DTX2P1-UPK3BP1-PMS2P11 FAIM2 FAM85A FLT3 FRS3 FTO GGNBP2 GPRC5B IGHMBP2 KANSL1 LIN28B LIN7C MAP2K5 MC4R METTL21A MFHAS1 MTIF3 NADK NCOA1 NEGR1 ORAOV1 PM20D1 POLK RASAL2-AS1 RASSF1 RBL2 RP11-347C12.2 RP11-568K15.1 SAE1 SEC16B SH2B1 SLC25A17 SRR SSBP3 TEAD3 TFAP2D TM2D1 TMEM161A TMEM18 TTC26 UHRF1BP1
Arm fat percentage (left) 7.96 54 35 106.1 0.93 5.8e-30 ACP2 ACSM5 ADCY3 ADCY9 AF131215.2 AF131215.9 AKTIP AL137059.1 C12orf62 C18orf8 C1QTNF4 C3orf38 CERS5 CLDN23 CTC-498M16.2 DNAJC27 DTX2P1-UPK3BP1-PMS2P11 FAIM2 FAM228B FAM85A FLT3 FTO GGNBP2 GPR153 GPRC5B LIN7C MADD MAP2K5 MC4R MFHAS1 MTCH2 MTIF3 NCOA1 NDUFS3 NEGR1 NLRC3 PIK3C3 POLK POMC PTRHD1 RASA2 RASAL2-AS1 RASSF1 RBL2 RP11-347C12.2 RP11-568K15.1 SAE1 SEC16B SH2B1 SRR TM2D1 TMEM18 UHRF1BP1 Y_RNA
Average weekly red wine intake 1.83 3 1 3.0 0.00 1.0e+00 C18orf8 CADM2 CTC-498M16.2
Mood swings 2.20 5 3 9.1 -0.99 4.1e-06 AF131215.2 AF131215.9 C1QTNF4 MADD MTCH2
Loneliness, isolation 2.39 6 3 9.1 -0.87 2.1e-03 C1QTNF4 MADD MTCH2 NDUFS3 TTC26 Y_RNA
Long-standing illness, disability or infirmity 1.54 2 0 0.0 0.00 1.0e+00 HDLBP NEGR1
Diabetes diagnosed by doctor 1.69 2 0 0.0 0.00 1.0e+00 AKTIP SAE1
Friendships satisfaction 1.24 1 0 0.0 0.00 1.0e+00 C18orf8
Qualifications: nursing, teaching 1.22 1 1 3.0 0.00 1.0e+00 NEGR1
Medication for cholesterol 1.60 2 2 6.1 0.00 1.0e+00 ATG7 FUT2
Mineral and other dietary supplements 1.63 1 0 0.0 0.00 1.0e+00 CTC-498M16.2
Asthma (self-reported) 1.23 1 0 0.0 0.00 1.0e+00 NHP2L1
Smoking status: Current 2.52 8 0 0.0 0.12 7.6e-01 AF131215.2 AF131216.5 C1QTNF4 FAM85A MFHAS1 MTCH2 TDH Y_RNA
Forced expiratory volume in 1-second (FEV1), predicted percentage 1.54 2 1 3.0 0.00 1.0e+00 RP11-347C12.2 SH2B1
Whole body water mass 3.86 56 44 133.3 0.74 2.0e-12 ACSM5 ADCY9 AF131215.2 AF131215.9 AKTIP AL137059.1 C11orf24 C12orf62 C18orf8 C1QTNF4 C3orf38 CADM2 CERS5 CTC-498M16.2 DOT1L DTX2P1-UPK3BP1-PMS2P11 FAIM2 FAM85A FGFR4 FLT3 FRS3 FTO GPRC5B IGHMBP2 KANSL1 LIN28B LIN7C MAP2K5 MC4R METTL21A MFHAS1 MTCH2 MTIF3 NADK NCOA1 NEGR1 ORAOV1 PINX1 PM20D1 POLK RASAL2-AS1 RASSF1 RBL2 RP11-347C12.2 RP11-568K15.1 SAE1 SEC16B SH2B1 SLC25A17 SSBP3 TEAD3 TM2D1 TMEM161A TMEM18 TTC26 UHRF1BP1
Leg predicted mass (right) 4.40 55 44 133.3 0.86 7.9e-20 ACSM5 ADCY9 AF131215.2 AF131215.9 AKTIP AL137059.1 ARMC6 C11orf24 C12orf62 C18orf8 C3orf38 CADM2 CERS5 CTC-498M16.2 DOT1L DTX2P1-UPK3BP1-PMS2P11 FAIM2 FAM85A FLT3 FRS3 FTO GGNBP2 GPRC5B IGHMBP2 KANSL1 LIN7C MAP2K5 MC4R METTL21A MFHAS1 MTIF3 NADK NCOA1 NEGR1 ORAOV1 PM20D1 POLK RASAL2-AS1 RASSF1 RBL2 RP11-347C12.2 RP11-568K15.1 SAE1 SEC16B SH2B1 SLC25A17 SRR SSBP3 TEAD3 TFAP2D TM2D1 TMEM161A TMEM18 TTC26 UHRF1BP1
Arm fat mass (left) 7.36 61 52 157.6 0.94 2.6e-37 ACP2 ACSM5 ADCY3 ADCY9 AF131215.2 AF131215.9 AKTIP AL137059.1 C12orf62 C18orf8 C1QTNF4 C3orf38 CADM2 CERS5 CTC-498M16.2 DNAJC27 DTX2P1-UPK3BP1-PMS2P11 FAIM2 FAM85A FLT3 FRS3 FTO GGNBP2 GPR153 GPRC5B KANSL1 LIN7C MADD MAP2K5 MC4R METTL21A MFHAS1 MTCH2 MTIF3 NADK NDUFS3 NEGR1 NLRC3 ORAOV1 PIK3C3 POLK POMC PTRHD1 RASA2 RASAL2-AS1 RASSF1 RBL2 RP11-347C12.2 RP11-568K15.1 SAE1 SEC16B SH2B1 SRR SSBP3 TEAD3 TFAP2D TM2D1 TMEM18 TYW3 UHRF1BP1 Y_RNA
Number of self-reported non-cancer illnesses 1.40 1 1 3.0 0.00 1.0e+00 NEGR1
Miserableness 2.92 11 7 21.2 -0.98 2.8e-11 AF131215.2 AF131215.9 AF131216.5 C1QTNF4 CLDN23 FAM120AOS FAM85A MADD MFHAS1 MTCH2 Y_RNA
Guilty feelings 2.92 8 2 6.1 -0.61 8.1e-02 AF131215.2 AF131215.9 AF131216.5 C1QTNF4 FAM85A LIN28B MADD MTCH2
Commuting to job workplace: Public transport 1.40 1 0 0.0 0.00 1.0e+00 NEGR1
Medication: Blood pressure 2.08 8 3 9.1 -0.28 4.4e-01 AF131215.2 AF131215.9 AF131216.5 ATG7 FAM85A FUT2 MFHAS1 NCOA1
Supplements: Fish oil (including cod liver oil) 1.58 1 1 3.0 0.00 1.0e+00 C11orf80
High cholesterol (Self-reported) 1.72 4 3 9.1 -0.20 8.0e-01 ARMC6 FUT2 POLK TMEM161A
Medication: Bendroflumethiazide 2.05 4 2 6.1 -0.09 8.8e-01 AF131215.2 AF131215.9 AF131216.5 MFHAS1
Illnesses of father: High blood pressure 1.54 1 0 0.0 0.00 1.0e+00 NCOA1
Alcohol drinker status: Never 1.47 1 0 0.0 0.00 1.0e+00 Y_RNA
Ever smoked 1.83 5 1 3.0 0.56 3.3e-01 CADM2 MAP2K5 PTPN23 SH3YL1 SRR
Basal metabolic rate 4.15 55 43 130.3 0.81 7.5e-16 ACSM5 ADCY9 AF131215.2 AF131215.9 AKTIP AL137059.1 C11orf24 C12orf62 C18orf8 C3orf38 CADM2 CERS5 CTC-498M16.2 DOT1L DTX2P1-UPK3BP1-PMS2P11 FAIM2 FAM85A FGFR4 FLT3 FRS3 FTO GGNBP2 GPRC5B IGHMBP2 KANSL1 LIN28B LIN7C MAP2K5 MC4R METTL21A MFHAS1 MTIF3 NADK NCOA1 NEGR1 ORAOV1 PINX1 PM20D1 POLK RASAL2-AS1 RASSF1 RBL2 RP11-347C12.2 RP11-568K15.1 SAE1 SEC16B SH2B1 SLC25A17 SSBP3 TEAD3 TFAP2D TM2D1 TMEM18 TTC26 UHRF1BP1
Leg fat percentage (left) 6.25 40 29 87.9 0.94 3.0e-24 ACP2 ADCY3 ADCY9 AF131215.2 AKTIP C12orf62 C18orf8 C1QTNF4 C3orf38 CALCRL CERS5 CTC-498M16.2 DNAJC27 DTX2P1-UPK3BP1-PMS2P11 FAIM2 FAM228B FAM85A FTO GGNBP2 GPR153 LIN7C MADD MAP2K5 MC4R MTCH2 NCOA1 NDUFS3 NEGR1 NLRC3 PIK3C3 POLK POMC PTRHD1 RASA2 RASAL2-AS1 RBL2 RP11-347C12.2 SH2B1 UHRF1BP1 Y_RNA
Arm fat-free mass (left) 4.00 54 41 124.2 0.76 5.8e-13 ACSM5 ADCY9 AF131215.2 AF131215.9 AKTIP AL137059.1 C11orf24 C12orf62 C18orf8 C1QTNF4 C3orf38 CADM2 CERS5 CTC-498M16.2 DOT1L DTX2P1-UPK3BP1-PMS2P11 FAIM2 FAM85A FGFR4 FLT3 FRS3 FTO GGNBP2 GPRC5B IGHMBP2 LIN7C MAP2K5 MC4R METTL21A MFHAS1 MTCH2 MTIF3 NADK NCOA1 NEGR1 ORAOV1 PINX1 PM20D1 POLK RASAL2-AS1 RASSF1 RBL2 RP11-347C12.2 RP11-568K15.1 SAE1 SEC16B SH2B1 SLC25A17 SSBP3 TEAD3 TM2D1 TMEM18 TTC26 UHRF1BP1
Number of operations (self-reported) 1.57 1 0 0.0 0.00 1.0e+00 LIN28B
Average weekly beer plus cider intake 2.47 3 0 0.0 -0.38 6.2e-01 AF131215.2 AF131215.9 AF131216.5
Irritability 2.86 6 6 18.2 -0.99 2.7e-07 AF131215.2 AF131215.9 AF131216.5 CLDN23 FAM85A MFHAS1
Risk taking 2.05 2 1 3.0 -0.21 7.9e-01 AF131215.2 CADM2
Ever had prostate specific antigen (PSA) test 1.46 1 0 0.0 0.00 1.0e+00 CTC-498M16.2
Fractured/broken bones in last 5 years 1.71 1 0 0.0 0.00 1.0e+00 IGHMBP2
Diastolic blood pressure, automated reading 2.27 16 8 24.2 0.21 3.8e-01 AF131215.2 AF131215.9 AF131216.5 C1QTNF4 CLDN23 FAM85A HDGFRP3 MADD MAP2K5 MECR MFHAS1 NCOA1 PINX1 SMARCD1 SRR TMEM127
Unable to work because of sickness or disability 1.59 1 0 0.0 0.00 1.0e+00 FAM85A
Myopia 1.74 2 0 0.0 0.00 1.0e+00 C1QTNF4 TMEM161A
Vascular/heart problems diagnosed by doctor 2.12 14 6 18.2 -0.24 3.0e-01 ACP2 AF131215.2 AF131215.9 ATG7 FAM85A FUT2 GPR153 MADD MAP2K5 MFHAS1 NCOA1 NEGR1 RP11-347C12.2 SRR
Cholesterol lowering medication 1.33 2 1 3.0 0.00 1.0e+00 FUT2 POLK
Pain experienced in last month 1.16 2 0 0.0 0.00 1.0e+00 FAM120AOS RP11-347C12.2
Alcohol drinker status: Previous 1.06 1 0 0.0 0.00 1.0e+00 RASSF1
Impedance of whole body 5.38 69 52 157.6 -0.86 1.6e-23 ACSM5 ADAM23 ADCY3 ADCY9 AF131215.2 AF131215.9 AF131216.5 AKTIP AL137059.1 C11orf24 C18orf8 CADM2 CERS5 CLDN23 CLOCK CTC-498M16.2 DNAJC16 DNAJC27 DTX2P1-UPK3BP1-PMS2P11 FAIM2 FAM85A FLT3 FRS3 FTO GGNBP2 GPRC5B HAPLN4 IGHMBP2 LIMA1 LIN28B LIN7C LINC00476 MAP2K5 MAP3K11 MC4R METTL21A MFHAS1 MTIF3 NADK NEGR1 NHP2L1 NLRC3 ORAOV1 PINX1 PM20D1 POLK POMC PTPN23 RASAL2-AS1 RASSF1 RBL2 RIT1 RP11-347C12.2 RP11-568K15.1 SAE1 SEC16B SH3YL1 SLC25A17 SMARCD1 SREK1IP1 SRR TDH TEAD3 TFAP2D TMEM161A TMEM18 TTC26 TYW3 UHRF1BP1
Leg fat mass (left) 6.87 54 43 130.3 0.93 2.5e-31 ACP2 ACSM5 ADCY3 ADCY9 AF131215.2 AF131215.9 AKTIP AL137059.1 C12orf62 C18orf8 C1QTNF4 C3orf38 CADM2 CERS5 CTC-498M16.2 DNAJC27 DTX2P1-UPK3BP1-PMS2P11 FAIM2 FAM85A FLT3 FTO GGNBP2 GPR153 GPRC5B LIN7C MADD MAP2K5 MC4R METTL21A MFHAS1 MTCH2 MTIF3 NADK NDUFS3 NEGR1 NLRC3 PIK3C3 POLK POMC PTRHD1 RASA2 RASAL2-AS1 RASSF1 RBL2 RP11-347C12.2 RP11-568K15.1 SAE1 SEC16B SH2B1 TEAD3 TM2D1 TMEM18 UHRF1BP1 Y_RNA
Arm predicted mass (left) 3.97 55 42 127.3 0.76 1.3e-12 ACSM5 ADCY9 AF131215.2 AF131215.9 AKTIP AL137059.1 C11orf24 C12orf62 C18orf8 C1QTNF4 C3orf38 CADM2 CERS5 CTC-498M16.2 DOT1L DTX2P1-UPK3BP1-PMS2P11 FAIM2 FAM85A FGFR4 FLT3 FRS3 FTO GGNBP2 GPRC5B IGHMBP2 LIN7C MAP2K5 MC4R METTL21A MFHAS1 MTCH2 MTIF3 NADK NCOA1 NEGR1 ORAOV1 PINX1 PM20D1 POLK RASAL2-AS1 RASSF1 RBL2 RP11-347C12.2 RP11-568K15.1 SAE1 SEC16B SH2B1 SH3YL1 SLC25A17 SSBP3 TEAD3 TM2D1 TMEM18 TTC26 UHRF1BP1

Associations by panel

study tissue # hits % hits/tests avg chisq
GTEx Adipose Subcutaneous 47 1.346 3.05
GTEx Adipose Visceral Omentum 23 1.130 2.94
GTEx Adrenal Gland 14 0.961 2.93
GTEx Artery Aorta 42 1.411 2.89
GTEx Artery Coronary 12 1.014 2.84
GTEx Artery Tibial 47 1.250 2.99
GTEx Brain Caudate basal ganglia 10 1.087 3.03
GTEx Brain Cerebellar Hemisphere 15 1.007 2.80
GTEx Brain Cerebellum 22 1.110 2.79
GTEx Brain Cortex 15 1.449 3.20
GTEx Brain Frontal Cortex BA9 12 1.299 3.06
GTEx Brain Hippocampus 5 0.954 2.93
GTEx Brain Hypothalamus 6 1.017 2.87
GTEx Brain Nucleus accumbens basal ganglia 10 1.156 2.84
GTEx Brain Putamen basal ganglia 6 0.962 2.83
GTEx Breast Mammary Tissue 25 1.266 2.92
GTEx Breast Mammary Tissue (Male) 12 1.006 2.79
GTEx Breast Mammary Tissue (Female) 15 0.912 2.82
GTEx Cells EBV-transformed lymphocytes 14 0.984 3.27
GTEx Cells Transformed fibroblasts 38 0.905 2.76
GTEx Colon Sigmoid 10 0.684 2.72
GTEx Colon Transverse 24 1.163 2.90
GTEx Esophagus Gastroesophageal Junction 17 1.176 2.88
GTEx Esophagus Mucosa 37 1.114 2.84
GTEx Esophagus Muscularis 42 1.300 2.91
GTEx Heart Atrial Appendage 21 1.330 2.95
GTEx Heart Left Ventricle 23 1.503 3.18
GTEx Liver 6 0.837 2.96
GTEx Lung 40 1.392 3.00
GTEx Muscle Skeletal 37 1.280 2.84
GTEx Nerve Tibial 44 1.018 2.99
GTEx Ovary 14 1.542 3.37
GTEx Pancreas 18 1.103 2.77
GTEx Pituitary 14 1.256 2.95
GTEx Prostate 13 1.557 3.15
GTEx Skin Not Sun Exposed Suprapubic 32 1.301 2.81
GTEx Skin Sun Exposed Lower leg 44 1.209 2.83
GTEx Small Intestine Terminal Ileum 7 1.518 3.18
GTEx Spleen 17 1.205 3.09
GTEx Stomach 16 1.100 2.87
GTEx Testis 32 1.014 2.94
GTEx Thyroid 39 0.975 2.70
GTEx Uterus 9 1.587 3.16
GTEx Vagina 11 1.732 3.20
GTEx Whole Blood 21 1.054 3.42
METSIM Adipose 32 0.694 2.49
NTR Blood 19 0.791 2.56
ROSMAP Brain Pre-frontal Cortex 59 1.344 2.97
YFS Blood 31 0.671 2.46
CommonMind Brain Pre-frontal Cortex 52 0.967 2.80
TCGA Breast Tumor 17 2.216 3.08
TCGA Breast Normal 22 0.523 2.36
TCGA Ovarian Tumor 22 0.753 2.26
TCGA Prostate Tumor 28 0.809 2.52